Halozyme Therapeutics Inc (HALO)
Operating profit margin
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating income (ttm) | US$ in thousands | 551,475 | 477,009 | 402,091 | 379,314 | 337,574 | 311,048 | 306,061 | 245,663 | 267,531 | 249,556 | 241,850 | 300,837 | 275,902 | 296,992 | 261,705 | 198,213 | 144,255 | 34,569 | -30,267 | -73,799 |
Revenue (ttm) | US$ in thousands | 1,015,324 | 947,355 | 873,304 | 862,989 | 829,253 | 780,710 | 773,653 | 704,980 | 660,116 | 580,623 | 487,477 | 471,567 | 443,310 | 463,010 | 412,496 | 331,262 | 267,594 | 199,556 | 180,470 | 164,397 |
Operating profit margin | 54.32% | 50.35% | 46.04% | 43.95% | 40.71% | 39.84% | 39.56% | 34.85% | 40.53% | 42.98% | 49.61% | 63.80% | 62.24% | 64.14% | 63.44% | 59.84% | 53.91% | 17.32% | -16.77% | -44.89% |
December 31, 2024 calculation
Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $551,475K ÷ $1,015,324K
= 54.32%
Halozyme Therapeutics Inc's operating profit margin has displayed a mix of negative and positive trends over the analyzed period. Starting at a low of -44.89% in March 2020, the operating profit margin improved consistently, turning positive by September 2020 at 17.32%, and increasing significantly to 53.91% by December 2020. The company maintained a strong performance in the following quarters, reaching peak levels of 64.14% in September 2021.
However, from December 2021 to March 2022, there was a slight decline in the operating profit margin, which rebounded in June 2022 to 49.61%. Subsequently, a decreasing trend was observed, with the operating profit margin falling to 40.53% by December 2022.
In the following quarters, there was some fluctuation, but the operating profit margin generally improved, reaching 54.32% by December 2024. This indicates that the company has managed to maintain a generally healthy level of operating profitability, with some fluctuations in between. It is important for stakeholders to monitor these trends closely to assess the company's ability to generate profits from its core operations.
Peer comparison
Dec 31, 2024